The burden of primary diseases is substantial, demanding fresh therapeutic modalities. Cellular therapies represent a remarkably exciting avenue, offering the possibility to regenerate damaged liver tissue and enhance clinical outcomes. Currently, research focuses on several techniques, including the administration of induced pluripotent regenerati